参考文献/References:
[1] Burcelin R,Nicolas S,Blasco-Baque V.Microbiotes and metabolic diseases:the bases for therapeutic strategies[J].Med Sci(Paris),2016,32(11):952-960.DOI:10.1051/medsci/20163211010.
[2] Davis-Richardson AG,Triplett EW.A model for the role of gut bacteria in the development of autoimmunity for type 1 diabetes[J].Diabetologia,2015,58(7):1386-1393.DOI:10.1007/s00125-015-3614-8.
[3] Clarke G,Stilling RM,Kennedy PJ,et al.Minireview: gut microbiota:the neglected endocrine organ[J].Mol Endocrinol,2014,28(8):1221-1238.DOI:10.1210/me.2014-1108.
[4] de la Cuesta-Zuluaga J,Kelley ST,Chen Y,et al.Age- and sex-dependent patterns of gut microbial diversity in human adults[J].mSystems,2019,4(4):pii:e00261-e00319.DOI:10.1128/mSystems.00261-19.
[5] Zhou L,Li X,Ahmed A,et al.Gut microbe analysis between hyperthyroid and healthy individuals[J].Curr Microbiol,2014,69(5):675-680.DOI:10.1007/s00284-014-0640-6.
[6] Ishaq HM,Mohammad IS,Shahzad M,et al.Molecular alteration analysis of human gut microbial composition in Graves' disease patients[J].Int J Biol Sci,2018,14(11):1558-1570.DOI:10.7150/ijbs.24151.
[7] Shi TT,Xin Z,Hua L,et al.Alterations in the intestinal microbiota of patients with severe and active Graves' orbitopathy: a cross-sectional study[J].J Endocrinol Invest,2019,42(8):967-978. DOI:10.1007/s40618-019-1010-9.
[8] Covelli D,Ludgate M.The thyroid, the eyes and the gut:a possible connection[J].J Endocrinol Invest,2017,40(6):567-576. DOI:10.1007/s40618-016-0594-6.
[9] Fröhlich E,Wahl R.Microbiota and thyroid interaction in health and disease[J].Trends Endocrinol Metab,2019,30(8):479-490.DOI:10.1016/j.tem.2019.05.008.
[10] Dayan CM,Daniels GH.Chronic autoimmune thyroiditis[J].N Engl J Med,1996,335(2):99-107.DOI:10.1056/NEJM199607113350206.
[11] Mori K,Nakagawa Y,Ozaki H.Does the gut microbiota trigger Hashimoto's thyroiditis?[J].Discov Med,2012,14(78):321-326.
[12] Lauritano EC,Bilotta AL,Gabrielli M,et al.Association between hypothyroidism and small intestinal bacterial overgrowth[J].J Clin Endocrinol Metab,2007,92(11):4180-4184.DOI:10.1210/jc.2007-0606.
[13] Ishaq HM,Mohammad IS,Guo H,et al.Molecular estimation of alteration in intestinal microbial composition in Hashimoto's thyroiditis patients[J].Biomed Pharmacother,2017,95:865-874. DOI:10.1016/j.biopha.2017.08.101.
[14] Roager HM,Hansen LB,Bahl MI,et al.Colonic transit time is related to bacterial metabolism and mucosal turnover in the gut[J].Nat Microbiol,2016,1(9):16093.DOI:10.1038/nmicrobiol.2016.93.
[15] Zhao F,Feng J,Li J,et al.Alterations of the gut microbiota in Hashimoto's thyroiditis patients[J].Thyroid,2018,28(2):175-186. DOI:10.1089/thy.2017.0395.
[16] Cosorich I,Dalla-Costa G,Sorini C,et al.High frequency of intestinal TH17 cells correlates with microbiota alterations and disease activity in multiple sclerosis[J].Sci Adv,2017,3(7):e1700492.DOI:10.1126/sciadv.1700492.
[17] Khegai II,Gulyaeva MA,Popova NA,et al.Immune system in vasopressin-deficient rats during ontogeny[J].Bull Exp Biol Med,2003,136(5):448-450.DOI:10.1023/b:bebm.0000017089.28428.1c.
[18] Tomkovich S,Jobin C.Microbiota and host immune responses:a love-hate relationship[J].Immunology,2016,147(1):1-10.DOI:10.1111/imm.12538.
[19] Desbonnet L,Clarke G,O'Sullivan O,et al. Re:gut microbiota depletion from early adolescence in mice:implications for brain and behaviour[J].Brain Behav Immun,2015,50:335-336.DOI:10.1016/j.bbi.2015.07.011.
[20] Fields CT,Chassaing B,Paul MJ,et al.Vasopressin deletion is associated with sex-specific shifts in the gut microbiome[J].Gut Microbes,2018,9(1):13-25.DOI:10.1080/19490976.2017.1356557.
[21] Sofi MH,Gudi R,Karumuthil-Melethil S,et al.pH of drinking water influences the composition of gut microbiome and type 1 diabetes incidence[J].Diabetes,2014,63(2):632-644.DOI:10.2337/db13-0981.
[22] Rokkas T,Pistiolas D,Sechopoulos P,et al.Risk of colorectal neoplasm in patients with acromegaly: a meta-analysis[J].World J Gastroenterol,2008,14(22):3484-3489.DOI:10.3748/wjg.14.3484
[23] Resmini E,Parodi A,Savarino V,et al.Evidence of prolonged orocecal transit time and small intestinal bacterial overgrowth in acromegalic patients[J].J Clin Endocrinol Metab,2007,92(6):2119-2124.DOI:10.1210/jc.2006-2509.
[24] Lacy BE,Weiser K.Gastrointestinal motility disorders: an update[J].Dig Dis,2006,24(3-4):228-242.DOI:10.1159/000092876.
[25] Thomas LA,Veysey MJ,Murphy GM,et al.Octreotide induced prolongation of colonic transit increases faecal anaerobic bacteria, bile acid metabolising enzymes, and serum deoxycholic acid in patients with acromegaly[J].Gut,2005,54(5):630-635.DOI:10.1136/gut.2003.028431.
[26] Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group.Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome(PCOS)[J].Hum Reprod,2004,19(1):41-47.DOI:10.1093/humrep/deh098.
[27] Velmurugan G,Ramprasath T,Gilles M,et al.Gut microbiota, endocrine-disrupting chemicals, and the diabetes epidemic[J].Trends Endocrinol Metab,2017,28(8):612-625.DOI:10.1016/j.tem.2017.05.001.
[28] Tang WH,Kitai T,Hazen SL.Gut Microbiota in cardiovascular health and disease[J].Circ Res,2017,120(7):1183-1196.DOI:10.1161/CIRCRESAHA.117.309715.
[29] Moran CP,Shanahan F.Gut microbiota and obesity:role in aetiology and potential therapeutic target[J].Best Pract Res Clin Gastroenterol,2014,28(4):585-597.DOI:10.1016/j.bpg.2014.07.005.
[30] Flak MB,Neves JF,Blumberg RS.Immunology. Welcome to the microgenderome[J].Science,2013,339(6123):1044-1045.DOI:10.1126/science.1236226.
[31] Thackray VG.Sex,microbes, and polycystic ovary syndrome[J].Trends Endocrinol Metab,2019,30(1):54-65.DOI:10.1016/j.tem.2018.11.001.
[32] Zeng B,Lai Z,Sun L,et al.Structural and functional profiles of the gut microbial community in polycystic ovary syndrome with insulin resistance(IR-PCOS): a pilot study[J].Res Microbiol,2019,170(1):43-52.DOI:10.1016/j.resmic.2018.09.002.
[33] Torres PJ,Siakowska M,Banaszewska B,et al.Gut microbial diversity in women with polycystic ovary syndrome correlates with hyperandrogenism[J].J Clin Endocrinol Metab,2018,103(4):1502-1511. DOI:10.1210/jc.2017-02153.
[34] Insenser M,Murri M,Del Campo R,et al.Gut microbiota and the polycystic ovary syndrome:influence of sex, sex hormones, and obesity[J].J Clin Endocrinol Metab,2018,103(7):2552-2562.DOI:10.1210/jc.2017-02799.
[35] Yurtda G,Akdeveliogˇlu Y.A new approach to polycystic ovary syndrome: the gut microbiota[J].J Am Coll Nutr,2019,12:1-12.DOI:10.1080/07315724.2019.1657515.
[36] Lindheim L,Bashir M,Münzker J,et al.Alterations in gut microbiome composition and barrier function are associated with reproductive and metabolic defects in women with polycystic ovary syndrome(PCOS): a pilot study[J].PLoS One,2017,12(1):e0168390. DOI:10.1371/journal.pone.0168390.
[37] Kelley ST,Skarra DV,Rivera AJ,et al.The gut microbiome is altered in a letrozole-induced mouse model of polycystic ovary syndrome[J].PLoS One,2016,11(1):e0146509.DOI:10.1371/journal.pone.0146509.
[38] Guo Y,Qi Y,Yang X,et al.Association between polycystic ovary syndrome and gut microbiota[J].PLoS One,2016,11(4):e0153196.DOI:10.1371/journal.pone.0153196.
[39] Quaranta G,Sanguinetti M,Masucci L.Fecal microbiota transplantation: a potential tool for treatment of human female reproductive tract diseases[J].Front Immunol,2019,10:2653.DOI:10.3389/fimmu.2019.02653.
[40] Tremellen K,Pearce K.Dysbiosis of gut microbiota(DOGMA)--a novel theory for the development of polycystic ovarian syndrome[J].Med Hypotheses,2012,79(1):104-112.DOI:10.1016/j.mehy.2012.04.016.
相似文献/References:
[1]刘艳清 易秋艳 邵加庆.肠道菌群与肥胖和糖尿病的关系[J].国际内分泌代谢杂志,2015,(01):31.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.007]
Liu Yanqing,Yi Qiuyan,Shao Jiaqing..Relationship between gut microbiota, obesity and diabetes[J].International Journal of Endocrinology and Metabolism,2015,(03):31.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.007]
[2]姚旻 赵爱源 张宏.肠道菌群与2型糖尿病[J].国际内分泌代谢杂志,2015,(01):35.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.008]
Yao Min*,Zhao Aiyuan,Zhang Hong..Relationship between gut microbiota and type 2 diabetes[J].International Journal of Endocrinology and Metabolism,2015,(03):35.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.008]
[3]林天烨,方文军.肠道菌群与代谢性疾病的关系[J].国际内分泌代谢杂志,2014,(04):277.[doi:10.3760/cma.j.issn.1673-4157.2014.04.018]
Lin Tianye*,Fang Wenjun..Relationship between microbiota and metabolic diseases[J].International Journal of Endocrinology and Metabolism,2014,(03):277.[doi:10.3760/cma.j.issn.1673-4157.2014.04.018]
[4]郑仁东 刘超.炎性反应与甲状腺肿瘤[J].国际内分泌代谢杂志,2015,(06):417.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.06.015]
Zheng Rendong,Liu Chao.Inflammation and thyroid tumor[J].International Journal of Endocrinology and Metabolism,2015,(03):417.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.06.015]
[5]郑仁东,刘超.碳酸锂与内分泌功能紊乱[J].国际内分泌代谢杂志,2017,37(03):186.[doi:10.3760/cma.j.issn.1673-4157.2017.03.011]
Zheng Rendong,Liu Chao..Lithium and endocrine disturbances[J].International Journal of Endocrinology and Metabolism,2017,37(03):186.[doi:10.3760/cma.j.issn.1673-4157.2017.03.011]
[6]狄红杰,刘超.饮食干预对非酒精性脂肪性肝病肠道菌群的影响[J].国际内分泌代谢杂志,2017,37(04):254.
Di Hongjie,Liu Chao..Effects of diet interventions on gut microbiota of nonalcoholic fatty liver disease[J].International Journal of Endocrinology and Metabolism,2017,37(03):254.
[7]唐榕 木良善.Akkermansia.muciniphila与代谢性疾病[J].国际内分泌代谢杂志,2018,38(01):36.[doi:10.3760/cma.j.issn.1673-4157.2018.01.010]
Tang Rong*,Mu Liangshan.Akkermansia.muciniphila and metabolic diseases[J].International Journal of Endocrinology and Metabolism,2018,38(03):36.[doi:10.3760/cma.j.issn.1673-4157.2018.01.010]
[8]贺文娟 钟燕.肠道菌群及其代谢产物与肥胖的关系[J].国际内分泌代谢杂志,2018,38(01):40.[doi:10.3760/cma.j.issn.1673-4157.2018.01.011]
He Wenjuan,Zhong Yan..Relationship between gut microbiota,its metabolites and obesity[J].International Journal of Endocrinology and Metabolism,2018,38(03):40.[doi:10.3760/cma.j.issn.1673-4157.2018.01.011]
[9]赫晓晴 单忠艳.肠道菌群与自身免疫性甲状腺疾病[J].国际内分泌代谢杂志,2020,40(03):179.[doi:10.3760/cma.j.issn.1673-4157.2020.03.008]
He Xiaoqing,Shan Zhongyan.Gut microbiota and autoimmune thyroid disease[J].International Journal of Endocrinology and Metabolism,2020,40(03):179.[doi:10.3760/cma.j.issn.1673-4157.2020.03.008]
[10]王瑜 崔景秋.肠道菌群与白色脂肪棕色化及棕色脂肪活化的关系[J].国际内分泌代谢杂志,2020,40(03):188.[doi:10.3760/cma.j.issn.1673-4157.2020.03.010]
Wang Yu,Cui Jingqiu.Relationship between gut microbiota and browning of white adipose tissue, activation of brown adipose tissue[J].International Journal of Endocrinology and Metabolism,2020,40(03):188.[doi:10.3760/cma.j.issn.1673-4157.2020.03.010]
[11]浮迎迎,刘超,蔡可英.肠道菌群与甲状腺稳态的关系[J].国际内分泌代谢杂志,2017,37(02):98.[doi:10.3760/cma.j.issn.1673-4157.2017.02.007]
Fu Yingying*,Liu Chao,Cai Keying..Relationship between intestinal bacteria and thyroid homeostasis[J].International Journal of Endocrinology and Metabolism,2017,37(03):98.[doi:10.3760/cma.j.issn.1673-4157.2017.02.007]